With the FDA tightening its guidance around the production of nonbacterial beta-lactam drugs, Swedish CDMO Recipharm is ...

Operating under the FDA's 503B pathway, the Apex facility will prioritize the production of generic shortage-listed ...

While the threat of U.S. import tariffs prompted a surge in drug production last year, that output is slated to slow across multiple geographies in 2026. | While the threat of U.S. import tariffs ...

XINTAI, SHANDONG, CHINA, January 19, 2026 /EINPresswire.com/ -- In recent years, the global pharmaceutical packaging ...

For much of the past decade, drug shortages in the United States were treated as episodic disruptions. In 2024, that framing ...

WENZHOU, ZHEJIANG PROVINCE, CHINA, January 19, 2026 /EINPresswire.com/ -- As the global pharmaceutical and healthcare ...

PharmaCloud offers DeepHow’s AI-powered platform within a validated, audit-ready cloud for regulated manufacturing.

“Our customers, in partnership with federal and state agencies, are reshoring drug manufacturing in the U.S., the world’s largest pharmaceutical market. Local API production is vital for supply chain ...

Tariffs and significant US manufacturing investments complicate ROI calculations and increase operational costs, challenging ...

AbbVie (ABBV) has agreed to acquire a device manufacturing facility in Tempe, Arizona and associated intellectual property from West Pharmaceutical Services (WST). West Pharmaceutical is selling all ...

SAN DIEGO, CA - January 27, 2026 (NEWMEDIAWIRE) - Quantumzyme Corp. (OTC: QTZM), a biotransformation company focused on sustainable pharmaceutical manufacturing, today announced a breakthrough ...